The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Statement 3.4
“Hospital pharmacists must ensure that an appropriate system for quality control, quality assurance and traceability is in place for pharmacy prepared and compounded medicines.”
What does it mean for patients? In case of adverse events a patient has the right to receive all information necessary to check whether the event was unavoidable and not due to ineffective treatment. Thus a tracking system is necessary to assure the information flow.
What does it mean for healthcare professionals? In case of adverse events, doctors or nurses should have the possibility to examine the manufacturing records to see whether the produced medicines fulfilled all quality requirements. This is only possible if the pharmacy implements an appropriate tracking system
What does it mean for Hospital Pharmacists? In case of adverse events the pharmacy has to demonstrate that all quality requirements were fulfilled in the production of the medicine of interest.
Hospital pharmacists should:
- Define written procedures for all individual preparations
- Record all individual preparations in a database
- Create a tracking system
The Hospital Universitario Clinico San Carlos is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
- QUANTIFICATION OF WAITING TIME REDUCTION IN OUTPATIENT SETTING USING ASSISTED SYSTEMS IN AN AUTOMATED ONCOLOGY PHARMACY.
- OPTIMIZATION OF RISK MANAGEMENT OF DRUGS COLD CHAIN IN HOSPITAL BY FAILURE MODES, EFFECTS AND CRITICALITY ANALYSIS "FMECA" METHOD
- DEVELOPMENT OF NEW PRODUCTION WHEN NEITHER PACKAGING NOR SOME OF THE RAW MATERIALS CONFORM TO EUROPEAN STANDARDS
- HOW TO HANDLE ACTIVE AND PLACEBO DRUGS FOR A CLINICAL TRIAL IN THE PRODUCTION SYSTEM CATO IN ORDER TO SECURE THE BLIND AND TO ENSURE THE EXACT SAME PREPARATION OF ACTIVE AND PLACEBO PRODUCTS
- EAHP Policy Statement on eHealth and mHealth
- EAHP Survey results 2016/2017 (sections 1,3 and 4)
- EAHP Survey Report 2015
- GPI: IMPROVING STAFF TRAINING IN A CYTOTOXICS PREPARATION UNIT
- GPI:Implementing chemotherapy dose-banding using retrospective data analysis and exponential calculus
- GPI: DEVELOPMENT OF A COMPUTER APPLICATION TO REDUCE THE RISK OF ERRORS IN RECONSTITUTION OF CYTOTOXIC DRUGS
- EAHP Brochure